These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 3117606

  • 1. Permeability changes in blood-retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors.
    Lightman S, Rechthand E, Terubayashi H, Palestine A, Rapoport S, Kador P.
    Diabetes; 1987 Nov; 36(11):1271-5. PubMed ID: 3117606
    [Abstract] [Full Text] [Related]

  • 2. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.
    Das A, Frank RN, Zhang NL, Samadani E.
    Exp Eye Res; 1990 Mar; 50(3):269-80. PubMed ID: 2108050
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats.
    Vinores SA, McGehee R, Lee A, Gadegbeku C, Campochiaro PA.
    J Histochem Cytochem; 1990 Sep; 38(9):1341-52. PubMed ID: 2117624
    [Abstract] [Full Text] [Related]

  • 5. The polyol pathway in retinal microangiopathy.
    Robison WG, Kinoshita JH, Kador PF.
    Drugs; 1986 Sep; 32 Suppl 2():19-22. PubMed ID: 3098542
    [Abstract] [Full Text] [Related]

  • 6. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
    Tilton RG, Pugliese G, LaRose LS, Faller AM, Chang K, Province MA, Williamson JR.
    J Diabet Complications; 1991 Sep; 5(4):230-7. PubMed ID: 1779018
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
    Datiles M, Fukui H, Kuwabara T, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevention of nerve edema and increased blood-nerve barrier permeability-surface area product in galactosemic rats by aldose reductase or thromboxane synthetase inhibitors.
    Wadhwani KC, Caspers-Velu LE, Murphy VA, Smith QR, Kador PF, Rapoport SI.
    Diabetes; 1989 Nov; 38(11):1469-77. PubMed ID: 2559867
    [Abstract] [Full Text] [Related]

  • 11. Permeability changes at blood-retinal barrier in diabetes and effect of aldose reductase inhibition.
    Lightman S, Pinter G, Yuen L, Bradbury M.
    Am J Physiol; 1990 Sep; 259(3 Pt 2):R601-5. PubMed ID: 2118733
    [Abstract] [Full Text] [Related]

  • 12. Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor.
    Robison WG, Kador PF, Kinoshita JH.
    Science; 1983 Sep 16; 221(4616):1177-9. PubMed ID: 6612330
    [Abstract] [Full Text] [Related]

  • 13. Galactose feeding causes glomerular hyperperfusion: prevention by aldose reductase inhibition.
    Bank N, Coco M, Aynedjian HS.
    Am J Physiol; 1989 Jun 16; 256(6 Pt 2):F994-9. PubMed ID: 2500030
    [Abstract] [Full Text] [Related]

  • 14. [Diabetic changes in pupillary reactions and iris histology. No. 3. The role of aldose reductase inhibitor to iridal vessel hyperpermeability of galactose-fed rats].
    Kador PF, Kinoshita JH, Terubayashi H, Akagi Y, Kador PF, Kinoshita JH.
    Nippon Ganka Gakkai Zasshi; 1988 Oct 16; 92(10):1577-81. PubMed ID: 3145680
    [No Abstract] [Full Text] [Related]

  • 15. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.
    Vinores SA, Van Niel E, Swerdloff JL, Campochiaro PA.
    Exp Eye Res; 1993 Dec 16; 57(6):723-35. PubMed ID: 8150024
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat.
    Robison WG, Kador PF, Akagi Y, Kinoshita JH, Gonzalez R, Dvornik D.
    Diabetes; 1986 Mar 16; 35(3):295-9. PubMed ID: 3081393
    [Abstract] [Full Text] [Related]

  • 20. Permeability of the blood-retinal and blood-aqueous barriers in galactose-fed rats.
    Caspers-Velu LE, Wadhwani KC, Rapoport SI, Kador PF.
    J Ocul Pharmacol Ther; 1995 Mar 16; 11(3):469-87. PubMed ID: 8590278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.